Perrigo Company plc Loss Contingency, Damages Sought, Value
Perrigo Company plc (PRGO) had Loss Contingency, Damages Sought, Value of ILS 2.70 billion as of 2017-06-28, per its 10-Q filed 2018-11-08.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency, Information about Litigation Matters
us-gaap:LossContingencyDamagesSoughtValue · last filed 2018-11-08
- 2017-06-28: Loss Contingency, Damages Sought, Value 2.70B ILS.
- 2017-03-29: Loss Contingency, Damages Sought, Value 686.00M ILS.
ILS
| Period end | Loss Contingency, Damages Sought, Value |
|---|---|
| 2017-06-28 | 2.70B ILS 10-Q · filed 2018-11-08 |
| 2017-03-29 | 686.00M ILS 10-Q · filed 2018-08-09 |
USD
| Period end | Loss Contingency, Damages Sought, Value | Loss Contingency, Damages Sought, Value as first filed | Loss Contingency, Damages Sought, Value 3 month | Loss Contingency, Damages Sought, Value 6 month | Loss Contingency, Damages Sought, Value 9 month | Loss Contingency, Damages Sought, Value 12 month |
|---|---|---|---|---|---|---|
| 2017-06-28 | $760.00M 10-Q · filed 2018-11-08 | |||||
| 2017-03-29 | $192.00M 10-Q · filed 2018-08-09 | $187.00M 10-Q · filed 2017-05-30 | ||||
| 2015-06-27 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-13 | $0.00 derived: sum of 2 quarters · filed 2015-08-13 | $0.00 derived: sum of 3 quarters · filed 2015-08-13 | $72.50M 10-K · filed 2015-08-13 | ||
| 2015-03-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $0.00 derived: sum of 2 quarters · filed 2015-04-29 | $72.50M 10-Q · filed 2015-04-29 | |||
| 2014-12-27 | $0.00 derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $72.50M 10-Q · filed 2015-02-05 | ||||
| 2014-09-27 | $72.50M 8-K · filed 2014-11-20 | |||||
| 2014-06-28 | $72.50M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |